Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination

PLoS Pathogens

Volumn 7, Issue 11, 2011, Pages

  Sacher, Torsten ^a   Andrassy, Joachim ^b   Kalnins, Aivars ^b   Dölken, Lars ^a   Jordan, Stefan ^a   Podlech, Jürgen ^c   Ruzsics, Zsolt ^a   Jauch, Karl Walter ^b   Reddehase, Matthias J ^c   Koszinowski, Ulrich H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; HEART; HEART TRANSPLANTATION; KIDNEY; LIGHT; MOUSE; NONHUMAN; VIRUS REPLICATION; ANIMAL; KIDNEY TRANSPLANTATION; MUROMEGALOVIRUS; PATHOGENICITY; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VIREMIA; VIROLOGY;

CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MURINAE;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEART; HEART TRANSPLANTATION; KIDNEY; KIDNEY TRANSPLANTATION; MICE; MICE, TRANSGENIC; MUROMEGALOVIRUS; VIREMIA;

EID: 81755177744     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002366     Document Type: Article

References (43)

1. Fishman JA, Rubin RH, (1998) Infection in organ-transplant recipients. N Engl J Med 338: 1741-1751.
2. Pouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged A, Tardy JC, et al. (1993) Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 55: 851-857.
3. Plachter B, Sinzger C, Jahn G, (1996) Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res 46: 195-261.
4. Sinzger C, Digel M, Jahn G, (2008) Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325: 63-83.
5. Manez R, Kusne S, Rinaldo C, Aguado JM, St George K, et al. (1996) Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis 173: 1072-1076.
6. Collins TM, Quirk MR, Jordan MC, (1994) Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol 68: 6305-6311.
7. Griffith BP, Chen M, Isom HC, (1990) Role of primary and secondary maternal viremia in transplacental guinea pig cytomegalovirus transfer. J Virol 64: 1991-1997.
8. Eisenfeld L, Silver H, McLaughlin J, Klevjer-Anderson P, Mayo D, et al. (1992) Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 32: 205-209.
9. Gilbert GL, Hayes K, Hudson IL, James J, (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1: 1228-1231.
10. Grefte A, Harmsen MC, van der Giessen M, Knollema S, van Son WJ, et al. (1994) Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J Gen Virol 75 (Pt 8): 1989-1998.
11. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA, (1991) Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 65: 6581-6588.
12. van der Strate BW, Hillebrands JL, Lycklama a Nijeholt SS, Beljaars L, Bruggeman CA, et al. (2003) Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo. J Virol 77: 11274-11278.
13. Adler B, Sinzger C, (2009) Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread? Thromb Haemost 102: 1057-1063.
14. Grefte A, Blom N, van der Giessen M, van Son W, The TH, (1993) Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J Infect Dis 168: 1110-1118.
15. Grefte A, van der Giessen M, van Son W, The TH, (1993) Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 167: 270-277.
16. Percivalle E, Revello MG, Vago L, Morini F, Gerna G, (1993) Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 92: 663-670.
17. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, et al. (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76 (Pt 4): 741-750.
18. Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB, et al. (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72: 95-103.
19. Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, et al. (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83: 8869-8884.
20. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, et al. (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335: 624-630.
21. Koskinen PK, Nieminen MS, Krogerus LA, Lemstrom KB, Mattila SP, et al. (1993) Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 12: 724-729.
22. Salzberger B, Myerson D, Boeckh M, (1997) Circulating cytomegalovirus (CMV)-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection. J Infect Dis 176: 778-781.
23. Sacher T, Jordan S, Mohr CA, Vidy A, Weyn AM, et al. (2008) Conditional gene expression systems to study herpesvirus biology in vivo. Med Microbiol Immunol 197: 269-276.
24. Sacher T, Podlech J, Mohr CA, Jordan S, Ruzsics Z, et al. (2008) The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3: 263-272.
25. Chou SW, Norman DJ, (1988) The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients. Transplantation 46: 89-93.
26. Rubin RH, Wilson EJ, Barrett LV, Medearis DN, (1984) Primary cytomegalovirus infection following cardiac transplantation in a murine model. Transplantation 37: 306-310.
27. Shanley JD, Billingsley AM, Shelby J, Corry RJ, (1983) Transfer of murine cytomegalovirus infection by heart transplantation. Transplantation 36: 584-586.
28. Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA, (1975) The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293: 1109-1112.
29. Sagedal S, Nordal KP, Hartmann A, Degre M, Holter E, et al. (2000) A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 70: 1166-1174.
30. Toupance O, Bouedjoro-Camus MC, Carquin J, Novella JL, Lavaud S, et al. (2000) Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int 13: 413-419.
31. Fenner F, (1949) Mouse-pox; infectious ectromelia of mice; a review. J Immunol 63: 341-373.
32. Saederup N, Aguirre SA, Sparer TE, Bouley DM, Mocarski ES, (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 75: 9966-9976.
33. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL, (1998) Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177: 1465-1474.
34. Waldman WJ, Knight DA, Huang EH, Sedmak DD, (1995) Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 171: 263-272.
35. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, et al. (1994) Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68: 6243-6253.
36. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM, (2009) Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol 90: 33-43.
37. Böhm V, Simon CO, Podlech J, Seckert CK, Gendig D, et al. (2008) The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation. J Virol 82: 11637-11650.
38. Cicin-Sain L, Podlech J, Messerle M, Reddehase MJ, Koszinowski UH, (2005) Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 79: 9492-9502.
39. Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, et al. (2001) Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30: 36-44.
40. Wagner M, Jonjic S, Koszinowski UH, Messerle M, (1999) Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73: 7056-7060.
41. Menard C, Wagner M, Ruzsics Z, Holak K, Brune W, et al. (2003) Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol 77: 5557-5570.
42. Corry RJ, Winn HJ, Russell PS, (1973) Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.
43. Russell PS, Chase CM, Colvin RB, Plate JM, (1978) Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med 147: 1449-1468.